Lecanemab (BAN2401): an anti–beta-amyloid monoclonal antibody for the treatment of Alzheimer disease
Grace Vitek, Boris Decourt, Marwan Noel Sabbagh
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1080/13543784.2023.2178414
- Published
- Feb 1, 2023
- Venue
- Expert Opinion on Investigational Drugs
- DOI
- 10.1080/13543784.2023.2178414
- PubMed
- 36749830
- Categories
- Alzheimer's disease research and treatments
- Provenance
- openalex